Products

Paige Prostate
Paige
Oncology AI
AI-powered applications that aid in the detection and grading of prostate cancer on H&E-stained whole-slide images of prostate needle biopsies.

See all 1 product →

About Paige.AI

Paige.AI is a leading healthcare artificial intelligence (AI) company dedicated to revolutionizing cancer diagnostics and treatment through advanced computational pathology. The company leverages extensive datasets of digitized pathology slides, clinical reports, and genomic data to develop AI-powered solutions that enhance the precision and efficiency of cancer detection and characterization. For physicians, Paige’s technology acts as a tireless partner, assisting in the identification of subtle markers of disease, reducing the likelihood of false negatives, and streamlining diagnostic workflows to improve turnaround times for patients.

Paige’s portfolio includes AI-assisted diagnostic applications designed to support decision-making across various cancer types, such as Paige Prostate, Paige Breast Suite, Paige GI Suite, and PanCancer Detect. These tools not only aid in detecting and subtyping cancer but also in revealing molecular biomarkers directly from tissue samples, which traditionally require more time-consuming genetic testing. The company’s innovative approach, including its foundation models like Virchow and the co-pilot platform Paige Alba™, aims to integrate AI seamlessly into existing digital pathology workflows, empowering pathologists and oncologists with real-time insights for more informed and personalized treatment decisions.

Paige’s commitment to advancing precision medicine is underscored by its development of AI applications that can identify both common and rare cancer variants across different anatomic sites, and its focus on multimodal AI models that combine imaging, genomics, pathology, and language data. By automating routine tasks and providing an added layer of diagnostic confidence, Paige’s solutions enable healthcare professionals to focus on complex cases and deliver high-quality diagnoses with remarkable sensitivity and specificity.

Focus Areas

digital pathology cancer diagnosis AI-assisted diagnostics biomarker discovery computational pathology precision medicine foundation models oncology

Business Intelligence

TechnologyAI-first digital pathology platform, deep learning algorithms, computational pathology, foundation models (Virchow, PRISM), cloud-based (Microsoft Azure, AWS Cloud), integrates with LIS and image management systems, multimodal AI models (Large Vision Models with Large Language Models)

What Physicians Need to Know

Digital Pathology Platform
Paige.AI offers an end-to-end digital pathology solution, including the FDA-cleared FullFocusu2122 viewer and a robust data management system for whole-slide images (WSIs). Their platform supports complete digital pathology workflows and is designed for flexibility and scalability.
AI-Assisted Cancer Diagnosis
Specializes in AI applications for detecting, grading, and quantifying cancer across a wide range of tissue types (e.g., prostate, breast, GI, and over 40 other cancer types). Their AI tools are designed to support diagnostic decision-making, enhance accuracy, and reduce diagnostic errors. Paige Prostate Detect was the first FDA-authorized AI in pathology.
Biomarker Discovery
Leverages novel AI technologies to identify multiple molecular biomarkers directly from tissue samples, including HER2 status from H&E slides. Their OmniScreenu2122 technology can detect over 1600 biomarkers.
Computational Pathology Expertise
Utilizes proprietary computational pathology technology and advanced machine learning algorithms, trained on massive, diverse datasets of digitized pathology slides, to provide deep insights into cancer.
Precision Medicine & Oncology
Committed to revolutionizing cancer diagnostics and care by providing a deeper understanding of cancer's molecular and cellular complexities. Their solutions support precision medicine initiatives, enabling more precise diagnoses and targeted therapies. Paige Albau2122 is a multi-modal co-pilot aimed at transforming personalized medicine.
Pioneering Foundation Models
A leader in applying foundation models to cancer care, with models like Virchow (the first million-slide foundation model for cancer, trained on over 4 million digitized slides) and PRISM (a multi-modal AI combining Large Vision Models and Large Language Models for slide-level analysis and automated report generation). These models facilitate pan-cancer detection and efficient biomarker prediction.
Physician Tip

For physicians, Paige.AI's solutions offer significant advantages by enhancing diagnostic accuracy and confidence, streamlining workflows, and providing comprehensive cancer insights. The AI can act as a 'second read' tool, prioritize cases, and reduce the need for additional staining or external consultations, ultimately decreasing turnaround times. The ability to detect biomarkers directly from H&E slides can also optimize diagnostic pathways. The open platform allows for customization and integration with existing lab systems, making the transition to AI-assisted pathology smoother.

Paige.AI's platform is designed for advanced integration capabilities, featuring open APIs that allow for unlimited vendor-neutral integrations with existing digital pathology applications, WSI scanners, and Laboratory Information Systems (LIS). This flexibility enables labs to customize workflows and seamlessly access both Paige's AI solutions and third-party AI applications within a single environment. They also partner with other AI pathology companies like Aiforia and Mindpeak to integrate their algorithms.

Products by Paige.AI

1 product in the directory

Paige Prostate
Paige
Oncology AI
AI-powered applications that aid in the detection and grading of prostate cancer on H&E-stained whole-slide images of prostate needle biopsies.

Videos

News, demos, and interviews about Paige.AI.

Loading videos...

Videos load interactively. If none appear, search YouTube for Paige.AI →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

Paige.AI's solutions are designed to integrate seamlessly into existing digital pathology workflows, providing AI-assisted diagnostic decision support for cancer pathology. Their applications, such as Paige Prostate Suite, Breast Suite, and GI Suite, help pathologists detect, classify, and quantify cancer, aiming to improve diagnostic accuracy and efficiency. The Paige Platform offers flexible, vendor-neutral integrations with various scanners and LIS systems, streamlining case review and enabling access to both Paige and third-party AI applications.
Paige.AI's products address a wide range of oncology concerns, including the detection, grading, and quantification of cancer in prostate, breast, and gastrointestinal tissues, as well as over 40 other cancer types. Their flagship products like Paige PanCancer Detect are designed to identify suspicious regions across multiple tissues and organs, including rare cancers, helping pathologists triage cases more efficiently.
Paige.AI has achieved significant regulatory milestones, including the first FDA-approved AI application in pathology, Paige Prostate Detect, for primary diagnosis of prostate cancer. They also hold multiple FDA Breakthrough Device Designations for applications like Paige PanCancer Detect and Paige Breast Lymph Node, alongside numerous CE-IVDD and UKCA marks. The company emphasizes its commitment to meeting high regulatory standards to ensure the safety and efficacy of its clinical AI solutions.
Paige.AI leverages powerful foundation models, such as Virchow and PRISM, trained on vast datasets of digitized pathology slides, to accelerate biomarker discovery and advance precision medicine. These models enable the detection of over 1,600 clinically significant biomarkers directly from H&E-stained images, predict treatment response, and facilitate the development of novel computational pathology applications. This capability helps in patient stratification and optimizing therapeutic targeting.
Paige.AI has established key partnerships with industry leaders such as Microsoft, leveraging Azure for cloud infrastructure and collaborating on large-scale AI model development. Recently, Tempus announced the acquisition of Paige, aiming to significantly expand Tempus's dataset and accelerate AI efforts in precision medicine. This acquisition is expected to enhance Paige's reach and impact in transforming cancer diagnosis and treatment.
Specific pricing models for Paige.AI's digital pathology solutions are not publicly detailed in the provided search results. However, Paige.AI offers comprehensive services that include AI expertise, custom AI development, regulatory strategy, and commercialization support. Their partnerships, such as with Gestalt, aim to provide streamlined workflows and comprehensive support to users, ensuring seamless integration and enhanced diagnostic confidence.
Paige.AI's computational pathology platform enhances efficiency and throughput by automating cancer detection, grading, and quantification, which can significantly reduce slide evaluation times and diagnostic turnaround times. The platform integrates with existing lab systems, offers a digital case manager for prioritization, and provides real-time insights to help pathologists manage their workloads more effectively. Studies have shown that AI assistance can lead to substantial time savings and increased accuracy in diagnosis.

Related Companies

Spectrum Dynamics Medical is a pioneering medical device company focused on transforming nuclear medicine from analog to digital technology. They specialize in developing high-definition, solid-state based nuclear imaging technology, including digital SPECT (Single Photon Emission Computed Tomography) and SPECT/CT systems. Their products aim to meet the clinical needs and workflow demands of diagnostic imaging departments […]

Siemens Medical Solutions USA, Inc., operating as Siemens Healthineers USA, is a prominent medical technology company with a rich history spanning over 175 years, dedicated to pioneering breakthroughs in healthcare. As a subsidiary of the global Siemens Healthineers AG, the company offers a comprehensive portfolio that is central to clinical decision-making across the entire healthcare […]

Siemens Healthineers is a leading global medical technology company that pioneers breakthroughs in healthcare. The company focuses on medical technology and diagnostics, offering a wide range of products including imaging systems, laboratory diagnostics, and advanced therapies. Their innovations aim to improve patient outcomes and make healthcare more accessible and sustainable. Siemens Healthineers has a strong […]

Perimeter Medical Imaging AI is a medical technology company dedicated to transforming cancer surgery through the use of ultra-high-resolution, real-time, advanced imaging tools. The company’s mission is to address significant unmet medical needs in cancer surgery, particularly concerning positive margins and the resulting need for re-excisions. Their proprietary technology, including the S-Series Optical Coherence Tomography […]

PathologyAILab offers advanced digital cytology services, leveraging a multi-agent AI system for cervical cancer diagnosis. This innovative solution provides comprehensive image analysis to deliver precise and reliable diagnostic insights to healthcare professionals. The service aims to provide rapid results, typically within 2-4 hours, for urgent cases, enabling timely clinical decisions. The process involves submitting digital […]

Varian Medical Systems, now a Siemens Healthineers company, is a global leader in advanced radiation oncology solutions for comprehensive cancer treatment. The company develops and manufactures medical devices and software for treating cancer and other medical conditions using therapies such as radiotherapy, radiosurgery, proton therapy, and brachytherapy. Their product portfolio includes linear accelerators (LINACs), proton […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.